Drugs & medical

Updated safety review of breast implants underscores the continuing importance of monitoring for cancer; increased risk with highly textured (macro-textured) implants

New safety information

Read the official notice →
Date
2022-04-06
Country
Canada
Product
Breast implants
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2022-04-11
  2. CA
    Drugs & medicalType II

    Vitros® Immunodiagnostic Products

    Quality

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    Reveal Linq Mobile Manager

    Software defect

    Health CanadaOfficial notice →
  4. 2022-04-08
  5. CA
  6. 2022-04-06
  7. CA
    Drugs & medicalType III

    ORBAX: Labelling Issue

    Labelling

    Health CanadaOfficial notice →
  8. 2022-04-04
  9. CA
    Drugs & medicalType II

    Sara Plus

    Increased risk or new adverse events

    Health CanadaOfficial notice →
  10. CA
See all drugs & medical recalls →